Bridging the gap between publicly funded research and markets
by Kyle Briggs, David Durand, TJ Misra Originally published on Policy Options September 16, 2025 by Kyle Briggs, David Durand, TJ Misra Originally published on Policy Options September 16, 2025…
RevolKa Ltd. Joins Research and Development Program for Innovative Biologics Funded by the Japanese Agency for Medical Research and Development (AMED)
RevolKa Fueling Up AI Protein Engineering Platform-based Therapeutic Program SENDAI, Japan, June 30, 2025–(BUSINESS WIRE)–RevolKa Ltd. (RevolKa), a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform, called…